Clara Masó Albareda
Member of the Research Line Wound healing innovation
Email: clara.maso@uvic.cat
ORCID: 0000-0002-8633-2836
Scientific Profile: URECERCA
She is a Physical Therapist from the University of Vic – Central University of Catalonia (2015), a Nurse from the University of Vic – Central University of Catalonia (2018), and holds a Master’s degree in Comprehensive Management and Research of Chronic Wounds in University of Cantabria (2019). She first started in the field of chronic wounds with the completion of the Final Degree Project (TFG) in collaboration with the TR2Lab research group.
As a wound-specialised nurse with a certification from the Spanish advisory group for the study of pressure ulcers and chronic wounds (GNEAUPP), Clara works in a Clinical Wound Unit of an intermediate hospital where, for two decades, has been focused on the treatment of difficult-to-heal ulcers with the application of advanced therapies. Thereby, their expertise lies in autologous therapies such as PRP therapy, having participated in a granted project, and punch skin graftings. The latter is due to her doctoral thesis “Observational study of the effect of therapy with punch skin graftings in the treatment of complex skin wounds” with an industrial doctorate and a research intensification grant.
Within the TR2Lab group, she develops her activity in the research line of wound healing innovation (November 2019-present), that have as a long-term goal to be capable of innovating in novel individualized therapies and in improving the assistance organizational processes to increase the rate of healing cutaneous chronic wounds in the Clinical Wound Unit.
My last happenings:
Comprehensive proteomic profiling of platelet-rich plasma from elderly individuals: insights for autologous therapeutic applications
Authors: Anna Buisán-Farré, Montserrat Serra-Mas, Elisabet Sarri, Verónica Salgado-Pacheco, Gianluca Arauz-Garofalo, Antonia Odena-Caballol, Marta Vilaseca, Marina Gay, Marta Ferrer-Solà, Clara Masó-Albareda, Marta Casals-Zorita, Marta Otero-Viñas Clinical Proteomics. 2026 DOI: 10.1186/s12014-026-09630-3 Funding: Instituto de Salud Carlos III (PI19/01379 and PI24/00211), the European Union, the PECT Osona Transformació Social project (001-P-000382), the INVESTIGO programme (2022 INV-1 00037), and a doctoral fellowship from the University of Vic-Central University of Catalonia. Proteomics analyses were performed at the IRB Barcelona Mass Spectrometry and Proteomics Core Facility (IU16-015983). Read more Abstract Background Autologous platelet-rich plasma (PRP) is commonly used to enhance tissue repair. [...]
TR2Lab was present at ETRS 2026 Annual Meeting
Dr.Elisabet Sarri and PhD candidate Natalia Palacio, members of TR2Lab, participated in the ETRS 2026 Annual Meeting, "Research, Repair, Regenerate", held in Rouen, France, from 2 to 4 September 2026. Organized by the European Tissue Repair Society (ETRS), the meeting is recognized as one of the leading international forums for researchers and clinicians working in tissue repair, wound healing and regenerative medicine. The conference brought together experts from across Europe and beyond to discuss emerging strategies for improving wound healing, with scientific sessions covering topics such as inflammation and tissue repair, biomaterials and bioengineering, wound microbiology and biofilms, stem cells, [...]
Punch skin grafting for patients with no-option for revascularisation chronic limb-threatening ischaemia: A case series
Authors: Masó-Albareda, C*; Ferrer-Solà, M; Casals-Zorita, M; Palacio-Arronis, N; Espaulella-Panicot, J; Otero-Viñas, M. Journal of Vascular Nursing. 2026 DOI: 10.1016/j.jvn.2026.06.001 Read More Abstract Objective: No-option for revascularisation Chronic Limb-Threatening Ischaemia (CLTI) is often a terminal diagnosis for older patients, leading to survival and limb preservation rates that are of concern, as it frequently results in amputation and increased mortality. This study aimed to describe the clinical outcomes of wounds in patients with no-option CLTI treated with punch skin grafting (PSG), a partial-thickness skin transplantation procedure. Method: This clinical case series included patients with no-option for revascularisation CLTI [...]
